Explore the vast range of titles available.

Now little recognized by their neighbors, Southern Paiutes once had homelands that included much of the vast Colorado Plateau, Great Basin, and Mojave Desert. From the Four Corners' San Juan River to California's lower Colorado, from Death Valley to Canyonlands, from Capitol Reef to the Grand Canyon, Paiutes lived in many small, widespread communities. They still do, but the communities are fewer, smaller, and mostly deprived of the lands and resources that sustained traditional lives. To portray a people and the individuals who comprise it, William Logan Hebner and Michael L. Plyler relay Paiute voices and reveal Paiute faces, creating a space for them to tell their stories and stake claim to who they once were and now are.

Patterns of single nucleotide polymorphisms (SNPs) in eukaryotic DNA are traditionally attributed to selective pressure, drift, identity descent, or related factors—without accounting for ways in which bias during de novo SNP formation, itself, might contribute. A functional and phenotypic analysis based on evolutionary resilience of DNA points to decreased numbers of non-synonymous SNPs in human and other genomes, with a predominant component of SNP depletion in the human gene pool caused by robust preferences during de novo SNP formation (rather than selective constraint). Ramifications of these findings are broad, belie a number of concepts regarding human evolution, and point to a novel interpretation of evolving DNA across diverse species.

Mitochondrial dysfunction is thought to be a hallmark of traumatic brain injury (TBI) and plays a pivotal role in the resulting cellular injury. Cyclophilin D–mediated activation of the mitochondrial permeability transition pore has been suggested to contribute to this secondary injury cascade. Cyclosporine possesses neuroprotective properties that have been attributed to the desensitization of mitochondrial permeability transition pore activation. In vivo animal experiments have demonstrated neuroprotective effects of cyclosporine in more than 20 independent experimental studies in a multitude of different experimental models. However, the majority of these studies have been carried out in rodents. The aim of the present study was to evaluate the efficacy of a novel and cremophor/kolliphor EL–free lipid emulsion formulation of cyclosporine in a translational large animal model of TBI. A mild-to-moderate focal contusion injury was induced in piglets using a controlled cortical impact device. After initial step-wise analyses of pharmacokinetics and comparing with exposure of cyclosporine in clinical TBI trials, a 5-day dosing regimen with continuous intravenous cyclosporine infusion (20 mg/kg/day) was evaluated in a randomized and blinded placebo-controlled setting. Cyclosporine reduced the volume of parenchymal injury by 35%, as well as improved markers of neuronal injury, as measured with magnetic resonance spectroscopic imaging. Further, a consistent trend toward positive improvements in brain metabolism and mitochondrial function was observed in the pericontusional tissue. In this study, we have demonstrated efficacy using a novel cyclosporine formulation in clinically relevant and translatable outcome metrics in a large animal model of focal TBI.

Retinoic acid (RA) is a standard-of-care neuroblastoma drug thought to be effective by inducing differentiation. Curiously, RA has little effect on primary human tumors during upfront treatment but can eliminate neuroblastoma cells from the bone marrow during post-chemo maintenance therapy—a discrepancy that has never been explained. To investigate this, we treat a large cohort of neuroblastoma cell lines with RA and observe that the most RA-sensitive cells predominantly undergo apoptosis or senescence, rather than differentiation. We conduct genome-wide CRISPR knockout screens under RA treatment, which identify bone morphogenic protein (BMP) signaling as controlling the apoptosis/senescence vs differentiation cell fate decision and determining RA’s overall potency. We then discover that BMP signaling activity is markedly higher in neuroblastoma patient samples at bone marrow metastatic sites, providing a plausible explanation for RA’s ability to clear neuroblastoma cells specifically from the bone marrow, by seemingly mimicking interactions between BMP and RA during normal development. Retinoic acid is known to be effective against bone marrow metastatic neuroblastoma cells, but not primary tumors. Here, authors discover that bone morphogenetic protein signaling is responsible for determining neuroblastoma cell fate and sensitivity to retinoic acid.

Rationales, snippets of extracted text that explain an inference, have emerged as a popular framework for interpretable natural language processing (NLP). Rationale models typically consist of two cooperating modules: a selector and a classifier with the goal of maximizing the mutual information (MMI) between the \"selected\" text and the document label. Despite their promises, MMI-based methods often pick up on spurious text patterns and result in models with nonsensical behaviors. In this work, we investigate whether counterfactual data augmentation (CDA), without human assistance, can improve the performance of the selector by lowering the mutual information between spurious signals and the document label. Our counterfactuals are produced in an unsupervised fashion using class-dependent generative models. From an information theoretic lens, we derive properties of the unaugmented dataset for which our CDA approach would succeed. The effectiveness of CDA is empirically evaluated by comparing against several baselines including an improved MMI-based rationale schema on two multi aspect datasets. Our results show that CDA produces rationales that better capture the signal of interest.